Exploring gaps in GLP-1 research, care, and coverage

Healthcare Strategies

Konten disediakan oleh Xtelligent Healthcare Media. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Xtelligent Healthcare Media atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

3M ago 16:35

MP3•Beranda episode

GLP-1 drugs, like Ozempic, Wegovy, and Zepbound, have gained attention for their significant health impacts and anti-obesity effects. However, there continues to be a lot of unknowns surrounding these medications, their long-term impacts, and access.

Featuring: Dr. Lydia Alexander, an obesity medicine specialist, lifestyle specialist, president of the Obesity Medicine Association (OMA), Chief Medical Officer at Enara, and a medical chef.

In today’s episode, we’ll cover

The significant progress made in GLP-1 research, care delivery, and insurance coverage
Filling research gaps in GLP-1 care through longitudinal studies examining long-term medication effects and potential adverse reactions
Tips for providers managing patients on GLP-1 medications and patient-focused approaches to obesity management

And more!

To watch video clips from our podcast, subscribe to our YouTube channel, @Healthcare Strategies

Resources:

121 episode

#Business #Healthcare Strategies #Xtelligent Healthcare Media